Event Details
Dates: October 19–22, 2025
Location: McCormick Place, 2301 S Martin Luther King Dr, Chicago, IL 60616
Event Website: https://www.chestnet.org/learning-and-events/events/chest-annual-meeting
Event Overview
Cizzle Bio will attend the CHEST 2025 Annual Meeting, a premier gathering of clinicians, researchers, and thought leaders advancing pulmonary, critical care, and sleep medicine.
This year’s meeting, hosted in Chicago from October 19–22, celebrates 90 years of clinical leadership and innovation in chest medicine. With a focus on high-impact topics like hemodynamic monitoring, lung nodule risk stratification, pulmonary embolism, and biomarkers in lung disease, CHEST 2025 offers an essential platform for clinicians seeking to deliver more precise, proactive care.
Why We’re Attending
At Cizzle Bio, our work centers on a single, urgent truth: early detection saves lives. That’s why we are advancing CIZ1B, a biomarker-based blood test designed to detect early-stage lung cancer—when patients have the greatest chance of survival.
CHEST 2025 brings together the very leaders who guide diagnostic decision-making in pulmonary care. Our attendance reflects our commitment to supporting clinicians with tools that are:
Minimally invasive
Clinically validated (95% sensitivity, 96% NPV for Stage I lung cancer)
Accessible and scalable for broad clinical deployment
By joining this year’s conference, we’re continuing the critical conversation about how to detect lung cancer earlier, especially in high-risk and underserved populations, and how to empower physicians with the right tools at the right time.
About the Conference
CHEST 2025 will feature:
Expert-led sessions on biomarkers for lung nodule stratification and genetics in interstitial lung disease
Pre-meeting courses on October 18 for advanced and foundational learners
Opening keynote by Sean Swarner, a two-time cancer survivor and Everest climber, sharing his story of resilience
Clinical updates on emerging diagnostic technologies and treatment pathways
The Opening Session takes place Sunday, October 19, at 8:00 a.m. CT.
As we move toward a future where lung cancer can be found earlier and treated sooner, Cizzle Bio is proud to stand with the clinicians leading that charge.